TERN logo

Terns Pharmaceuticals, Inc. (TERN) Selling, General & Administrative Expenses

Annual SG&A:

$31.76M-$7.30M(-18.69%)
December 31, 2024

Summary

  • As of today, TERN annual SG&A is $31.76 million, with the most recent change of -$7.30 million (-18.69%) on December 31, 2024.
  • During the last 3 years, TERN annual SG&A has risen by +$12.21 million (+62.46%).
  • TERN annual SG&A is now -18.69% below its all-time high of $39.06 million, reached on December 31, 2023.

Performance

TERN SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNincome statement metrics

Quarterly SG&A:

$0.00-$7.03M(-100.00%)
September 30, 2025

Summary

  • As of today, TERN quarterly SG&A is $0.00, with the most recent change of -$7.03 million (-100.00%) on September 30, 2025.
  • Over the past year, TERN quarterly SG&A has dropped by -$9.77 million (-100.00%).
  • TERN quarterly SG&A is now -100.00% below its all-time high of $18.35 million, reached on September 30, 2023.

Performance

TERN Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNincome statement metrics

TTM SG&A:

-$1.83B-$94.44M(-5.44%)
September 30, 2025

Summary

  • As of today, TERN TTM SG&A is -$1.83 billion, with the most recent change of -$94.44 million (-5.44%) on September 30, 2025.
  • Over the past year, TERN TTM SG&A has dropped by -$1.86 billion (-6118.71%).
  • TERN TTM SG&A is now -1892.63% below its all-time high of -$91.86 million.

Performance

TERN TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

TERN Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-18.7%-100.0%-6118.7%
3Y3 Years+62.5%-100.0%-8551.7%
5Y5 Years+266.6%-100.0%-10000.0%

TERN Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-18.7%+62.5%-100.0%at low-124.8%at low
5Y5-Year-18.7%+266.6%-100.0%at low-1287.6%at low
All-TimeAll-Time-18.7%+714.1%-100.0%at low-1892.6%at low

TERN Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$0.00(-100.0%)
$23.68M(-29.2%)
Jun 2025
-
$7.03M(-19.3%)
$33.45M(-0.5%)
Mar 2025
-
$8.71M(+9.6%)
$33.61M(+5.8%)
Dec 2024
$31.76M(-18.7%)
$7.95M(-18.7%)
$31.76M(+4.4%)
Sep 2024
-
$9.77M(+36.0%)
$30.41M(-22.0%)
Jun 2024
-
$7.18M(+4.8%)
$39.00M(+0.5%)
Mar 2024
-
$6.86M(+3.9%)
$38.82M(-0.6%)
Dec 2023
$39.06M(+74.3%)
$6.60M(-64.0%)
$39.06M(+1.1%)
Sep 2023
-
$18.35M(+161.9%)
$38.63M(+52.0%)
Jun 2023
-
$7.01M(-1.3%)
$25.41M(+6.7%)
Mar 2023
-
$7.10M(+15.1%)
$23.82M(+6.3%)
Dec 2022
$22.41M
$6.17M(+20.2%)
$22.41M(+3.5%)
DateAnnualQuarterlyTTM
Sep 2022
-
$5.13M(-5.4%)
$21.66M(+2.0%)
Jun 2022
-
$5.42M(-4.7%)
$21.24M(+2.7%)
Mar 2022
-
$5.69M(+5.0%)
$20.68M(+5.8%)
Dec 2021
$19.55M(+117.3%)
$5.42M(+14.9%)
$19.55M(+29.2%)
Sep 2021
-
$4.71M(-2.9%)
$15.13M(+45.3%)
Jun 2021
-
$4.86M(+6.5%)
$10.42M(+29.5%)
Mar 2021
-
$4.56M(+357.0%)
$8.04M(+42.1%)
Dec 2020
$9.00M(+3.8%)
$998.00K(-59.9%)
$5.66M(-19.7%)
Jun 2020
-
$2.49M(+14.1%)
$7.05M(+54.4%)
Mar 2020
-
$2.18M(-8.8%)
$4.57M(+91.2%)
Dec 2019
$8.66M(+122.1%)
$2.39M
$2.39M
Dec 2018
$3.90M
-
-

FAQ

  • What is Terns Pharmaceuticals, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. annual SG&A year-on-year change?
  • What is Terns Pharmaceuticals, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
  • What is Terns Pharmaceuticals, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. TTM SG&A year-on-year change?

What is Terns Pharmaceuticals, Inc. annual SG&A?

The current annual SG&A of TERN is $31.76M

What is the all-time high annual SG&A for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high annual SG&A is $39.06M

What is Terns Pharmaceuticals, Inc. annual SG&A year-on-year change?

Over the past year, TERN annual SG&A has changed by -$7.30M (-18.69%)

What is Terns Pharmaceuticals, Inc. quarterly SG&A?

The current quarterly SG&A of TERN is $0.00

What is the all-time high quarterly SG&A for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high quarterly SG&A is $18.35M

What is Terns Pharmaceuticals, Inc. quarterly SG&A year-on-year change?

Over the past year, TERN quarterly SG&A has changed by -$9.77M (-100.00%)

What is Terns Pharmaceuticals, Inc. TTM SG&A?

The current TTM SG&A of TERN is -$1.83B

What is the all-time high TTM SG&A for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high TTM SG&A is -$91.86M

What is Terns Pharmaceuticals, Inc. TTM SG&A year-on-year change?

Over the past year, TERN TTM SG&A has changed by -$1.86B (-6118.71%)
On this page